Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 USD | -6.62% | -11.79% | -45.11% |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Glover
CEO | Chief Executive Officer | 60 | 13-12-31 |
Peter Wolfe
DFI | Director of Finance/CFO | 56 | 22-12-11 |
Pablo Guzman
CTO | Chief Tech/Sci/R&D Officer | 74 | 22-12-31 |
Karen Cashmere
PRN | Corporate Officer/Principal | 71 | 22-12-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CEO | Chief Executive Officer | 60 | 13-12-31 |
Robert Finizio
BRD | Director/Board Member | 53 | 22-11-30 |
James Sapirstein
BRD | Director/Board Member | 63 | 23-01-04 |
Gregory Freitag
BRD | Director/Board Member | 62 | 23-01-04 |
Min-Chul Park
BRD | Director/Board Member | 42 | 22-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,062 | 0 | 0 | 99.17 % |
Stock B | 1 | 759,493 | 753,188 ( 99.17 %) | 6 ( 0.000816 %) | |
Stock C | 0 | 50 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.11% | 3.75M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- ZVSA Stock
- Company ZyVersa Therapeutics, Inc.